# CXCL2/CXCL8 Promote Intervertebral Disc Degeneration

> **NCT05976516** · — · UNKNOWN · sponsor: **Zhongda Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Cytokine
- Intervertebral Disc, Degenerative

## Interventions

- **DIAGNOSTIC_TEST:** CXCL2/CXCL8

## Key facts

- **NCT ID:** NCT05976516
- **Lead sponsor:** Zhongda Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-01
- **Primary completion:** 2024-03-30
- **Final completion:** 2024-03-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05976516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05976516, "CXCL2/CXCL8 Promote Intervertebral Disc Degeneration". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05976516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*